Feasibility Study of Exenatide by Continuous Subcutaneous Infusion

NCT01857895 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity

Interventions

DRUG: Exenatide

Sponsor

GlaxoSmithKline

Collaborators

[object Object]